Table 3 Correlationsa between site for distant metastasis (DM) in relation to immune cell score (variable), i.e., presence of CD15+, MPO+, CD15/MPO+ immune cells, or CD15+ tumor cells (CD15+ TC) in the primary breast tumor (PT).
Site of recurrence | CD15+ | MPO+ | CD15+MPO+ | CD15+ TC | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Correlation Coefficient | P value (2-tailed) | N | Correlation Coefficient | P value (2-tailed) | N | Correlation Coefficient | P value (2-tailed) | N | Correlation Coefficient | P value (2-tailed) | N | |
Recurrent DM vs. de novo MBC | 0.031 | 0.756 | 104 | 0.304 | 0.001** | 114 | 0.301 | 0.001** | 114 | 0.057 | 0.544 | 114 |
DM Lymph nodes | − 0.036 | 0.719 | 104 | 0.005 | 0.959 | 114 | 0.083 | 0.380 | 114 | 0.008 | 0.937 | 114 |
DM Ascites | 0.062 | 0.529 | 104 | − 0.016 | 0.864 | 114 | − 0.095 | 0.313 | 114 | − 0.085 | 0.369 | 114 |
DM Pleura | − 0.150 | 0.130 | 104 | 0.074 | 0.437 | 114 | − 0.040 | 0.669 | 114 | − 0.010 | 0.917 | 114 |
DM Lung | − 0.014 | 0.885 | 104 | 0.177 | 0.059 | 114 | 0.041 | 0.664 | 114 | − 0.076 | 0.422 | 114 |
DM Liver | 0.125 | 0.206 | 104 | 0.025 | 0.790 | 114 | − 0.025 | 0.791 | 114 | − 0.057 | 0.549 | 114 |
DM Skin | − 0.228 | 0.020* | 104 | 0.094 | 0.318 | 114 | 0.117 | 0.215 | 114 | − 0.122 | 0.195 | 114 |
DM CNS | 0.148 | 0.134 | 104 | 0.157 | 0.095 | 114 | − 0.082 | 0.386 | 114 | 0.194 | 0.038* | 114 |
DM Skeleton | 0.124 | 0.210 | 104 | − 0.081 | 0.392 | 114 | − 0.176 | 0.061 | 114 | 0.084 | 0.376 | 114 |
DM other | − 0.031 | 0.756 | 104 | 0.023 | 0.808 | 114 | − 0.042 | 0.661 | 114 | − 0.162 | 0.085 | 114 |
DM bone only | − 0.030 | 0.760 | 104 | − 0.155 | 0.100 | 114 | 0.053 | 0.573 | 114 | 0.095 | 0.314 | 114 |
Number of sites | 0.058 | 0.557 | 104 | 0.089 | 0.344 | 114 | − 0.028 | 0.764 | 114 | − 0.075 | 0.425 | 114 |